Perlecan, the multidomain heparan sulfate proteoglycan of basement membranes, is also a prominent component of the cartilaginous primordia in the developing human fetal spine.
The aim of this study was to localize perlecan in human fetal spine tissues. Human fetal spines (12-20 weeks; n=6) were fixed in either Histochoice or 10% neutral buffered formalin, routinely processed, paraffin-embedded, and 4-microm sagittal sections were cut and stained with toluidine blue, H&E, and von Kossa. Perlecan, types I, II, IV, and X collagen, CD-31, aggrecan core protein, and native and delta-HS 4, 5 hexuronate stub epitopes were immunolocalized. Toluidine blue staining visualized the cartilaginous vertebral body (VB) rudiments and annular lamellae encompassing the nucleus pulposus (NP). Von Kossa staining identified the VB primary center of ossification. Immunolocalization of type IV collagen, CD-31, and perlecan delineated small blood vessels in the outer annulus fibrosus (AF) and large canals deep within the VBs. Perlecan and type X collagen were also prominently expressed by the hypertrophic vertebral growth plate chondrocytes. Aggrecan was extracellularly distributed in the intervertebral disk (IVD) with intense staining in the posterior AF. Notochordal tissue stained strongly for aggrecan but negatively for perlecan and types I and II collagen. Type I collagen was prominent in the outer AF and less abundant in the NP, while type II collagen was localized throughout the IVD and VB. The immunolocalization patterns observed indicated key roles for perlecan in vasculogenic, chondrogenic, and endochondral ossification processes associated with spinal development.
D053674:Aggrecans; D000918:Antibody Specificity; D001485:Basement Membrane / Q000378:metabolism; D002356:Cartilage / Q000196:embryology* / Q000254:growth & development / Q000378:metabolism*; D019902:Chondrocytes / Q000166:cytology / Q000378:metabolism; D011508:Chondroitin Sulfate Proteoglycans / Q000737:chemistry / Q000378:metabolism; D024121:Collagen Type X / Q000378:metabolism; D005314:Embryonic and Fetal Development; D004727:Endothelium / Q000166:cytology / Q000378:metabolism; D016326:Extracellular Matrix Proteins; D005333:Fetus; D006132:Growth Plate / Q000378:metabolism; D019812:Heparan Sulfate Proteoglycans / Q000032:analysis / Q000378:metabolism*; D006603:Hexuronic Acids / Q000276:immunology / Q000378:metabolism; D006801:Humans; D006984:Hypertrophy / Q000378:metabolism; D007150:Immunohistochemistry; D007403:Intervertebral Disc / Q000378:metabolism; D037181:Lectins, C-Type; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000378:metabolism; D011509:Proteoglycans / Q000378:metabolism; D013131:Spine / Q000196:embryology* / Q000254:growth & development / Q000378:metabolism*
D053674:Aggrecans; D011508:Chondroitin Sulfate Proteoglycans; D024121:Collagen Type X; D016326:Extracellular Matrix Proteins; D019812:Heparan Sulfate Proteoglycans; D006603:Hexuronic Acids; D037181:Lectins, C-Type; D019408:Platelet Endothelial Cell Adhesion Molecule-1; D011509:Proteoglycans; C071927:perlecan